Loading CNH…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("CNH","financials")Full statements spill as a table. For one cell: =jivedata("CNH","Revenue") or =jivedata("CNH","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
CNH • CIK 0001567094
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax | $22,080,000 | $17,060,000 | $15,346,000 | $15,466,000 |
| Revenues | $24,687,000 | $19,836,000 | $18,095,000 | $18,185,000 |
| Cost of Revenue | $16,838,000 | $13,350,000 | $12,389,000 | $12,629,000 |
| Selling, General and Administrative Expense | $1,863,000 | $1,712,000 | $1,876,000 | $1,971,000 |
| Research and Development Expense | $1,041,000 | $924,000 | $1,025,000 | $1,085,000 |
| Restructuring Charges | $67,000 | $128,000 | $22,000 | $42,000 |
| InterestExpenseOperating | — | $1,611,000 | $1,482,000 | $1,497,000 |
| Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | $2,703,000 | $1,457,000 | $620,000 | $368,000 |
| Income Tax Expense (Benefit) | $594,000 | $336,000 | $184,000 | $108,000 |
| Income (Loss) from Equity Method Investments | $274,000 | $138,000 | $69,000 | $47,000 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $2,383,000 | $1,259,000 | $505,000 | $307,000 |
| Net Income (Loss) Attributable to Noncontrolling Interest | $12,000 | $13,000 | $-5,000 | $-4,000 |
| Net Income (Loss) Attributable to Parent | $2,371,000 | $1,246,000 | $510,000 | $311,000 |
| Weighted Average Number of Shares Outstanding, Basic | 1,332,000,000 | 1,254,000,000 | 1,248,000,000 | 1,239,000,000 |
| Weighted Average Number of Shares Outstanding, Diluted | 1,350,000,000 | 1,260,000,000 | 1,251,000,000 | 1,240,000,000 |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 0 | 0 | 0 | 0 |
| Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | 18,000,000 | 6,000,000 | 3,000,000 | 1,000,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $4,322,000 | $3,191,000 | $2,578,000 | $1,868,000 |
| Restricted Cash and Cash Equivalents, Current | $723,000 | $675,000 | $651,000 | $596,000 |
| Financing Receivable, after Allowance for Credit Loss | $24,249,000 | $23,085,000 | $23,105,000 | $22,520,000 |
| Other Receivables | $380,000 | $168,000 | $195,000 | $238,000 |
| Inventory, Net | $5,545,000 | $4,776,000 | $4,651,000 | $5,171,000 |
| Property, Plant and Equipment, Net | $1,913,000 | $1,936,000 | $2,181,000 | $2,190,000 |
| Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures | $563,000 | $490,000 | $437,000 | $452,000 |
| Goodwill | $3,614,000 | $3,584,000 | $3,617,000 | $3,606,000 |
| Intangible Assets, Net (Excluding Goodwill) | $1,292,000 | $1,221,000 | $1,086,000 | $1,061,000 |
| Deferred Income Tax Assets, Net | $979,000 | $927,000 | $1,207,000 | $1,291,000 |
| Derivative Asset | $136,000 | $196,000 | $142,000 | $144,000 |
| Other Assets | $1,085,000 | $1,093,000 | $1,080,000 | $1,199,000 |
| Assets | $46,351,000 | $42,933,000 | $42,747,000 | $42,172,000 |
| Debt and Lease Obligation | $27,326,000 | $26,882,000 | $26,762,000 | $25,966,000 |
| Accounts Payable, Other | $146,000 | $62,000 | $91,000 | $78,000 |
| Accounts Payable, Trade | $3,611,000 | $2,292,000 | $2,247,000 | $2,412,000 |
| Deferred Income Tax Liabilities, Net | $35,000 | $28,000 | $17,000 | $14,000 |
| Liability, Defined Benefit Plan | $476,000 | $392,000 | $366,000 | $332,000 |
| Derivative Liability | $216,000 | $146,000 | $97,000 | $123,000 |
| Other Liabilities | $6,307,000 | $5,363,000 | $5,342,000 | $5,394,000 |
| Liabilities | $38,117,000 | $35,165,000 | $34,922,000 | $34,319,000 |
| Redeemable Noncontrolling Interest, Equity, Carrying Amount | $54,000 | $55,000 | $53,000 | $59,000 |
| Common Stock, Value, Issued | $25,000 | $25,000 | $25,000 | $25,000 |
| Treasury Stock, Value | $865,000 | $1,386,000 | $1,422,000 | $1,459,000 |
| Additional Paid in Capital, Common Stock | $1,578,000 | $1,415,000 | $1,388,000 | $1,360,000 |
| Retained Earnings (Accumulated Deficit) | $9,750,000 | $10,309,000 | $10,506,000 | $10,527,000 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-2,374,000 | $-2,712,000 | $-2,767,000 | $-2,697,000 |
| Stockholders' Equity Attributable to Noncontrolling Interest | $66,000 | $62,000 | $42,000 | $38,000 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $8,180,000 | $7,713,000 | $7,772,000 | $7,794,000 |
| Common Stock, Shares, Outstanding | 1,290,937,585 | 1,248,023,791 | 1,242,064,719 | 1,237,725,958 |
| Treasury Stock, Common, Shares | 73,462,611 | 116,376,405 | 122,335,477 | 126,674,238 |
| Deferred Tax Assets, Net | $944,000 | $899,000 | $1,190,000 | $1,190,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $2,383,000 | $1,259,000 | $505,000 | $307,000 |
| Net Cash Provided by (Used in) Operating Activities | $907,000 | $1,968,000 | $2,538,000 | $1,784,000 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | $110,000 | $-308,000 | $225,000 | $1,000 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $-84,000 | $-1,179,000 | $-637,000 | $-683,000 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $5,045,000 | $3,866,000 | $3,229,000 | $3,170,000 |
| Payments to Acquire Receivables | $8,069,000 | $8,227,000 | $7,554,000 | $7,143,000 |
| Proceeds from Sale and Collection of Receivables | $5,824,000 | $6,459,000 | $7,508,000 | $7,591,000 |
| Income (Loss) from Equity Method Investments, Net of Dividends or Distributions | $211,000 | $11,000 | $-17,000 | $3,000 |
| Other Noncash Income (Expense) | $-173,000 | $-329,000 | $-647,000 | $-676,000 |
| Payments for (Proceeds from) Other Investing Activities | $275,000 | $-181,000 | $136,000 | $-40,000 |
| Net Cash Provided by (Used in) Investing Activities | $-3,699,000 | $-2,772,000 | $-1,380,000 | $-685,000 |
| Proceeds from Issuance of Long-term Debt | $9,941,000 | $15,111,000 | $12,985,000 | $13,397,000 |
| Repayments of Long-term Debt | $8,224,000 | $13,453,000 | $13,006,000 | $14,028,000 |
| Proceeds from (Repayments of) Other Debt | $2,071,000 | $-416,000 | $-1,566,000 | $-856,000 |
| Payments of Dividends | $538,000 | $607,000 | $333,000 | $139,000 |
| Proceeds from (Payments for) Other Financing Activities | $-652,000 | $-702,000 | $-100,000 | $-157,000 |
| Net Cash Provided by (Used in) Financing Activities | $2,598,000 | $-67,000 | $-2,020,000 | $-1,783,000 |
| Cash and Cash Equivalents, at Carrying Value | $4,322,000 | $3,191,000 | $2,578,000 | $2,487,000 |
| Restricted Cash | $723,000 | $675,000 | $651,000 | $683,000 |
| Increase (Decrease) in Deferred Income Taxes | $535,000 | $107,000 | $198,000 | $240,000 |
| Increase (Decrease) in Receivables | $2,268,000 | $-1,015,000 | $-708,000 | $-255,000 |
| Increase (Decrease) in Inventories | $259,000 | $-787,000 | $-749,000 | $-364,000 |
| Increase (Decrease) in Accounts Payable | $-157,000 | $-1,186,000 | $-198,000 | $-13,000 |
| Increase (Decrease) in Other Operating Assets and Liabilities, Net | $-296,000 | $530,000 | $-15,000 | $-49,000 |